Language selection

Government of Canada / Gouvernement du Canada

Search

Respiratory Virus Report, Week 14 - ending April 6, 2024

Download in PDF format
(761 KB, 13 pages)

Organization: Public Health Agency of Canada

Please note that the Respiratory Virus Detection Surveillance System (RVDSS) is a sentinel laboratory surveillance system that does not capture all respiratory virus testing performed in Canada; differences may exist between the data presented in this report and provincial/territorial epidemiological reports. SARS-CoV-2 laboratory data is included in this report to facilitate the comparison of positivity with other respiratory viruses. Interpretation should be made with caution as testing practices differ among viruses.

For additional SARS-CoV-2 surveillance information, please refer to the COVID-19 epidemiology update.

Overall summary

In week 14 (week ending April 6, 2024) in Canada, participating RVDSS laboratories reported 1,369 detections of SARS-CoV-2 from 28,886 tests (4.7% positive). Among non-SARS-CoV-2 respiratory viruses, activity of influenza is highest.

  • National SARS-CoV-2 percent positivity has been decreasing since mid-December 2023.
  • Influenza A percent positivity has decreased in recent weeks (662 detections; 2.3% positive) and is lower than influenza B which is currently stable (1,949 detections; 6.7% positive).
  • RSV percent positivity has decreased in recent weeks (518 detections; 2.0% positive).
  • Percent positivity of all other non-SARS-CoV-2 respiratory viruses is within expected levels typical of this time of year.
  • 34/35 sentinel laboratories reported surveillance data

On this page

Abbreviations:
ADV
Adenovirus
Atl
Atlantic Canada
BC
British Columbia
Can
Canada
EORLA
Eastern Ontario Regional Laboratory Association
EV/RV
Enterovirus/Rhinovirus
Flu
Influenza
Flu A(H1)pdm09
Influenza A(H1N1)pdm09
Flu A(H3)
Influenza A(H3N2)
Flu A(UnS)
Influenza A(Unsubtyped)
HCoV
Human coronavirus 229E/OC43/NL63/HKU1
HMPV
Human metapneumovirus
HPIV
Human parainfluenza virus
HSC
Health Sciences Centre
N.C.
Data not collected
N.R.
Data not reported for current week
ON
Ontario
PR
Prairies
P.H.O.L.
Public Health Ontario Laboratory
QC
Quebec
RSV
Respiratory syncytial virus
RVDSS
Respiratory Virus Detection Surveillance System
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Terr
Territories of Canada
UHN
University Health Network

Respiratory virus detections

Table 1: Respiratory virus detections for the week ending April 6, 2024 (surveillance week 2024-14)
Reporting Laboratory SARS-CoV-2 Tested SARS-CoV-2 Positive Flu Tested A(H1)pdm09 Positive A(H3) Positive A(UnS) Positive Total Flu A Positive Total Flu B Positive RSV Tested RSV Positive HPIV Tested HPIV 1 Positive HPIV 2 Positive HPIV 3 Positive HPIV 4 Positive Other HPIV Positive ADV Tested ADV Positive HMPV Tested HMPV Positive EV/RV Tested EV/RV Positive HCoV Tested HCoV Positive
Newfoundland 557 48 436 0 0 3 3 19 436 22 436 1 2 11 4 0 436 6 436 24 436 36 436 36
Prince Edward Island 154 5 138 0 0 0 0 17 138 4 14 0 0 4 0 0 14 3 14 3 15 7 15 1
Nova Scotia 1278 83 1259 0 0 59 59 64 999 18 30 0 0 0 0 0 30 1 30 2 30 4 30 2
New Brunswick 975 42 1112 0 0 12 12 110 1112 30 117 0 0 6 0 0 117 2 117 16 117 16 117 4
Atlantic 2964 178 2945 0 0 74 74 210 2685 74 597 1 2 21 4 0 597 12 597 45 598 63 598 43
Région Nord-Est 1354 40 1473 0 0 11 11 156 688 37 88 0 0 1 1 0 88 4 84 13 N.C. N.C. 88 8
Québec-Chaudière-Appalaches 1264 22 1621 0 0 46 46 179 1559 67 642 0 0 6 0 0 657 19 642 43 N.C. N.C. 492 31
Centre-du-Québec 1850 44 1790 0 0 71 71 167 799 26 21 0 0 2 0 0 21 1 21 1 N.C. N.C. 22 1
Montréal-Laval 1956 55 2748 0 0 65 65 171 1623 32 859 0 2 37 0 0 859 21 862 48 N.C. N.C. 859 51
Ouest du Québec 1092 21 726 0 0 30 30 52 718 12 14 0 0 3 0 0 14 4 14 1 N.C. N.C. 14 0
Montérégie 1193 25 1321 0 0 25 25 63 1320 26 8 0 0 1 0 0 8 1 8 2 N.C. N.C. 8 0
Province of Québec 8709 207 9679 0 0 248 248 788 6707 200 1632 0 2 50 1 0 1647 50 1631 108 N.C. N.C. 1483 91
P.H.O.L. - Ottawa 271 57 278 6 0 7 13 5 278 5 164 0 0 0 0 4 164 0 164 22 164 9 164 25
EORLA 825 38 523 0 0 28 28 50 523 7 33 0 0 2 0 0 33 0 33 3 33 4 33 4
P.H.O.L. - Kingston 217 40 179 3 0 0 3 0 179 0 82 0 0 0 0 12 82 0 82 1 82 1 82 19
UHN / Mount Sinai Hospital 816 21 699 0 0 12 12 7 699 1 65 0 0 1 0 0 65 0 65 4 65 6 65 1
P.H.O.L. - Toronto 370 34 898 9 2 5 16 12 898 3 837 0 0 0 0 80 837 9 837 73 837 54 837 85
Sick Kids Hospital - Toronto 128 4 111 0 1 0 1 6 111 2 111 0 0 7 0 0 111 2 111 12 111 31 111 5
Shared Hospital Laboratory 1496 13 1180 13 5 2 20 28 1180 3 1178 0 0 0 0 10 1178 7 1182 25 1182 34 1182 13
P.H.O.L. - Sault Ste. Marie 27 8 37 3 0 1 4 0 37 1 20 0 0 0 0 0 20 0 20 0 20 0 20 4
P.H.O.L. - Timmins 19 1 46 5 0 0 5 0 46 3 37 0 0 0 0 1 37 1 37 3 37 2 37 6
St. Joseph's - London N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R. N.R.
P.H.O.L. - London 300 26 298 2 1 1 4 10 298 2 269 0 0 0 0 22 269 2 269 21 269 18 269 25
P.H.O.L. - Orillia 21 6 19 1 0 0 1 0 19 0 15 0 0 0 0 0 15 0 15 0 15 0 15 2
P.H.O.L. - Thunder Bay 34 0 31 3 0 1 4 0 31 0 22 0 0 0 0 1 22 0 22 1 22 0 22 1
P.H.O.L. - Sudbury 39 0 43 1 0 0 1 0 43 1 30 0 0 0 0 2 30 0 30 1 30 4 30 11
P.H.O.L. - Hamilton 64 4 75 0 0 1 1 3 75 0 59 0 0 0 0 4 59 1 59 7 59 4 59 7
P.H.O.L. - Peterborough 75 4 90 1 1 0 2 5 90 1 50 0 0 0 0 3 50 1 50 5 50 8 50 1
St. Joseph's - Hamilton 1605 39 1565 0 0 46 46 85 1565 7 1565 0 0 52 0 0 1565 7 1565 67 1565 100 0 0
Sault Area Hospital 121 7 110 4 0 0 4 0 110 2 93 0 0 2 0 0 93 4 93 12 93 10 93 0
Province of Ontario 6428 302 6182 51 10 104 165 211 6182 38 4630 0 0 64 0 139 4630 34 4634 257 4634 285 3069 209
Manitoba 1325 86 1062 1 0 16 17 70 1062 15 96 0 0 3 0 0 96 2 95 8 96 8 95 10
Saskatchewan 1613 77 1312 0 0 33 33 202 1059 38 384 0 0 17 0 0 384 3 384 14 384 28 384 30
Alberta 4267 160 4318 19 28 0 49 337 4151 69 1117 2 1 60 0 0 1117 9 1056 0 1099 96 1117 72
Prairies 7205 323 6692 20 28 49 99 609 6272 122 1597 2 1 80 0 0 1597 14 1535 22 1579 132 1596 112
British Columbia 3308 346 3351 13 10 5 75 97 3260 67 790 0 5 38 2 0 790 32 790 46 762 77 762 49
Yukon 56 0 36 0 0 0 0 2 36 0 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Northwest Territories 35 1 35 1 0 0 1 3 35 4 N.C. N.C. N.C. N.C. N.C. N.C. 35 1 35 1 35 5 N.C. N.C.
Nunavut 181 12 150 0 0 0 0 29 150 13 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Territories 272 13 221 1 0 0 1 34 221 17 N.C. N.C. N.C. N.C. N.C. N.C. 35 1 35 1 35 5 N.C. N.C.
CANADA 28886 1369 29070 85 48 480 662 1949 25327 518 9246 3 10 253 7 139 9296 143 9222 479 7608 562 7508 504

The data in the RVDSS report represent surveillance data available at the time of writing. Data missing from the current week are denoted by N.R. Data not collected by reporting lab denoted by N.C.

Some specimens from Yukon (YT) are sent to reference laboratories in British Columbia and reported results reflect specimens identified as originating from YT.

Results from British Columbia comprise of specimens from the following sites: Children's and Women's Hospital Laboratory, Fraser Health Medical Microbiology Laboratory, Island Health, Providence Health Care, Vancouver Coastal Health sites, Victoria General Hospital, BCCDC Public Health Laboratory, Interior Health Authority sites and Northern Health Authority sites.

Due to different testing protocols of laboratories across Canada, influenza A subtype detection counts may not be included in total influenza A detection counts. Total influenza A and B positive counts are used to calculate percentage of tests positive.

Delays in the reporting of data may cause data to change retrospectively.

Table 2: Cumulative respiratory virus detections from August 27, 2023 to April 6, 2024 (surveillance weeks 2023-35 to 2024-14)
Reporting Laboratory SARS-CoV-2 Tested SARS-CoV-2 Positive Flu Tested A(H1)pdm09 Positive A(H3) Positive A(UnS) Positive Total Flu A Positive Total Flu B Positive RSV Tested RSV Positive HPIV Tested HPIV 1 Positive HPIV 2 Positive HPIV 3 Positive HPIV 4 Positive Other HPIV Positive ADV Tested ADV Positive HMPV Tested HMPV Positive EV/RV Tested EV/RV Positive HCoV Tested HCoV Positive
Newfoundland 19785 2864 14500 0 0 1322 1322 120 14500 935 14500 17 69 51 105 0 14500 241 14500 312 14500 1150 14500 400
Prince Edward Island 7364 778 4798 0 0 541 541 213 4798 367 526 3 0 10 8 0 525 32 515 19 526 132 510 25
Nova Scotia 45760 8421 32206 0 0 2664 2664 401 26534 1420 1110 16 3 4 10 0 1110 41 1103 12 1110 224 1109 18
New Brunswick 34926 3893 32889 889 25 1906 2820 776 32485 1876 2940 7 4 26 30 0 2940 107 2940 89 2940 562 2940 120
Atlantic 107835 15956 84393 889 25 6433 7347 1510 78317 4598 19076 43 76 91 153 0 19075 421 19058 432 19076 2068 19059 563
Région Nord-Est 53904 7085 49135 5 0 4724 4729 794 19590 1429 2516 16 12 26 17 0 2516 108 2455 106 N.C. N.C. 2516 112
Québec-Chaudière-Appalaches 62778 9317 43393 0 0 5541 5541 1447 41643 2713 16624 22 9 35 14 0 17128 526 16624 530 N.C. N.C. 13648 485
Centre-du-Québec 78502 12444 39904 0 0 4542 4542 890 23178 1618 1158 15 8 21 7 0 1158 57 1158 52 N.C. N.C. 1190 44
Montréal-Laval 93893 13925 78831 5 2 6627 6634 703 50593 2894 26786 95 42 272 24 0 26786 525 26859 645 N.C. N.C. 26786 948
Ouest du Québec 51588 10039 22370 4 0 2085 2089 311 22150 1104 612 11 3 21 7 0 612 47 612 20 N.C. N.C. 612 28
Montérégie 50242 8034 41329 0 0 3211 3211 338 40251 1786 221 1 0 1 1 0 221 8 221 5 N.C. N.C. 221 3
Province of Québec 390907 60844 274962 14 2 26730 26746 4483 197405 11544 47917 160 74 376 70 0 48421 1271 47929 1358 N.C. N.C. 44973 1620
P.H.O.L. - Ottawa 10899 3778 7680 296 54 191 418 38 7674 137 4581 0 0 0 0 121 4581 13 4579 107 4581 430 4579 270
EORLA 40152 4537 18960 0 0 1604 1604 395 18960 1127 1248 2 5 28 4 0 1223 14 1248 32 1248 223 1248 41
P.H.O.L. - Kingston 7490 2113 4282 135 19 96 224 5 4282 168 2951 0 0 0 0 77 2951 11 2951 25 2951 331 2951 136
UHN / Mount Sinai Hospital 34527 3037 21798 41 10 552 603 79 21798 225 1404 0 0 20 2 0 1404 3 1404 11 1404 70 1404 44
P.H.O.L. - Toronto 18862 5454 34589 1175 911 345 1781 242 34580 1047 31754 0 0 0 0 1102 31762 368 31739 717 31754 2926 31739 1627
Sick Kids Hospital - Toronto 4087 311 3676 105 100 20 225 58 3676 312 3676 15 12 87 21 0 3676 99 3676 115 3676 666 3676 112
Shared Hospital Laboratory 55572 4546 46695 859 525 293 1677 386 46702 1341 46470 0 0 0 0 319 40816 337 46551 277 46596 1502 46573 529
P.H.O.L. - Sault Ste. Marie 479 206 589 55 3 17 69 1 589 46 404 0 0 0 0 5 404 1 404 0 404 21 404 42
P.H.O.L. - Timmins 1128 326 1148 63 10 30 92 7 1148 65 908 0 0 0 0 26 908 5 908 12 908 54 908 43
St. Joseph's - London 27420 3463 14953 0 0 965 965 210 14953 712 2080 0 0 0 0 34 2099 33 2099 32 2101 236 2099 58
P.H.O.L. - London 14561 4130 10894 485 142 169 611 100 10891 472 8788 0 0 0 0 270 8788 39 8786 128 8788 765 8786 358
P.H.O.L. - Orillia 575 150 1260 72 17 11 100 0 1257 74 1191 0 0 0 0 31 1191 16 1191 19 1191 145 1191 26
P.H.O.L. - Thunder Bay 1850 501 1163 61 0 9 42 5 1160 30 968 0 0 0 0 28 968 6 968 30 968 57 968 28
P.H.O.L. - Sudbury 754 239 901 43 1 23 67 1 899 26 640 0 0 0 0 23 641 1 640 9 640 51 640 61
P.H.O.L. - Hamilton 7125 2110 5915 149 66 98 258 40 5914 172 4461 0 0 0 0 144 4461 85 4460 118 4461 565 4460 214
P.H.O.L. - Peterborough 2327 670 2388 207 205 73 155 29 2378 222 1859 0 0 0 0 68 1859 39 1859 48 1859 297 1859 55
St. Joseph's - Hamilton 60601 5832 54028 0 0 3208 3208 731 54028 1769 54028 0 0 519 0 0 54028 337 54028 701 54028 3091 0 0
Sault Area Hospital 5926 789 4020 180 18 55 253 15 4013 205 3159 27 0 22 17 0 3110 40 3110 37 3110 267 3120 67
Province of Ontario 294335 42192 234939 3926 2081 7759 12352 2342 234902 8150 170570 44 17 676 44 2248 164870 1447 170601 2418 170668 11697 116605 3711
Manitoba 51459 7314 38783 145 12 1857 2014 445 38783 1368 2987 2 10 25 41 0 2987 124 3762 151 2987 534 3762 140
Saskatchewan 66021 7377 45421 117 10 5442 5569 1737 40518 1606 14665 30 9 113 25 0 14665 278 14665 779 14665 1387 14665 393
Alberta 172101 19853 150887 11796 779 586 13232 3457 141021 6153 41520 137 92 565 3 0 41509 480 40148 30 40862 3749 41519 1081
Prairies 289581 34544 235091 12058 801 7885 20815 5639 220322 9127 59172 169 111 703 69 0 59161 882 58575 960 58514 5670 59946 1614
British Columbia 122048 16240 123676 4070 818 266 8690 1103 120700 5892 28940 115 182 351 184 0 28942 902 28827 1157 27802 4173 27779 877
Yukon 1715 178 1122 34 15 0 60 7 1113 46 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Northwest Territories 1207 76 1145 167 6 1 174 51 1145 172 N.C. N.C. N.C. N.C. N.C. N.C. 946 45 946 10 1145 138 N.C. N.C.
Nunavut 4403 370 3154 432 33 52 517 189 3154 468 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Territories 7325 624 5421 633 54 53 751 247 5412 686 N.C. N.C. N.C. N.C. N.C. N.C. 946 45 946 10 1145 138 N.C. N.C.
CANADA 1212031 170400 958482 21590 3781 49126 76701 15324 857058 39997 325675 531 460 2197 520 2248 321415 4968 325936 6335 277205 23746 268362 8385

The data in the RVDSS report represent surveillance data available at the time of writing. Data not collected by reporting lab denoted by N.C.

Some specimens from Yukon (YT) are sent to reference laboratories in British Columbia and reported results reflect specimens identified as originating from YT.

Results from British Columbia comprise of specimens from the following sites: Children's and Women's Hospital Laboratory, Fraser Health Medical Microbiology Laboratory, Island Health, Providence Health Care, Vancouver Coastal Health sites, Victoria General Hospital, BCCDC Public Health Laboratory, Interior Health Authority sites and Northern Health Authority sites.

Due to different testing protocols of laboratories across Canada, influenza A subtype detection counts may not be included in total influenza A detection counts. Total influenza A and B positive counts are used to calculate percentage of tests positive.

Delays in the reporting of data may cause data to change retrospectively. Due to these delays, the sum of weekly report totals do not add up to cumulative totals.

Positive respiratory virus tests historical comparison

Figure 1: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, and respiratory syncytial virus tests (%) reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Figure 1

Shaded area represents the maximum and minimum % of respiratory virus tests positive reported by week from seasons 2014-2015 to 2019-2020

Note: Changes to testing practices during the COVID-19 pandemic may cause substantial changes to indicator estimates from previous years. Collection of laboratory testing practice meta-data to understand these changes is ongoing. Interpret trends with caution.

Note: SARS-CoV-2 surveillance was integrated into RVDSS at the beginning of the 2022-2023 season; no prior data is available for historical comparison.

Note: Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Figure 1: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, and respiratory syncytial virus tests (%) reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Week Week end 2023-2024 SARS-CoV-2% 2022-2023 SARS-CoV-2% 2023-2024 A% 2022-2023 A% 2021-2022 A% Max A% Base Min A% Base Av A% Base 2023-2024 B% 2022-2023 B% 2021-2022 B% Max B% Base Min B% Base Av B% Base 2023-2024 RSV% 2022-2023 RSV% 2021-2022 RSV% Max RSV% Base Min RSV% Base Av RSV% Base
35 2023-09-02 14.40 13.40 0.69 0.18 0.04 1.60 0.11 0.67 0.06 0.02 0.00 0.28 0.00 0.14 0.58 1.12 4.43 1.34 0.38 0.61
36 2023-09-09 15.92 13.07 0.43 0.14 0.01 2.11 0.23 0.99 0.06 0.04 0.00 0.55 0.00 0.15 0.71 1.12 6.61 1.09 0.22 0.62
37 2023-09-16 16.49 12.74 0.48 0.23 0.03 1.59 0.35 0.87 0.03 0.01 0.00 0.19 0.04 0.12 0.82 1.06 7.59 1.37 0.38 0.65
38 2023-09-23 18.60 13.62 0.51 0.48 0.00 2.15 0.43 1.17 0.02 0.02 0.00 0.21 0.00 0.14 1.15 1.47 7.16 1.24 0.37 0.67
39 2023-09-30 19.59 14.44 0.51 0.67 0.01 2.65 0.50 1.52 0.09 0.03 0.00 0.29 0.09 0.18 1.14 2.14 8.48 1.29 0.51 0.72
40 2023-10-07 19.81 15.06 0.64 0.96 0.00 2.17 1.01 1.58 0.05 0.03 0.02 0.20 0.05 0.11 1.35 2.54 8.53 1.39 0.34 0.71
41 2023-10-14 17.55 16.59 0.49 1.42 0.03 2.66 1.05 1.56 0.03 0.01 0.03 0.36 0.03 0.16 1.80 3.65 9.54 1.74 0.58 1.03
42 2023-10-21 17.78 15.39 0.73 2.36 0.03 2.96 0.77 1.92 0.08 0.05 0.02 0.45 0.05 0.25 2.38 4.63 8.18 2.11 0.63 1.25
43 2023-10-28 17.89 15.78 1.16 5.47 0.03 5.19 0.68 2.59 0.10 0.03 0.02 0.55 0.06 0.23 3.25 6.76 8.11 2.16 0.55 1.41
44 2023-11-04 17.74 13.91 2.63 10.75 0.10 8.32 1.08 3.35 0.10 0.03 0.10 0.71 0.12 0.31 4.07 7.77 7.82 3.35 0.83 2.07
45 2023-11-11 18.17 12.43 4.93 16.19 0.07 9.83 1.18 4.19 0.14 0.04 0.06 0.97 0.22 0.44 5.12 7.68 7.03 4.43 1.29 2.71
46 2023-11-18 18.80 11.96 7.24 20.23 0.10 13.89 1.42 5.43 0.16 0.05 0.06 1.49 0.09 0.57 5.85 7.54 7.18 6.33 1.38 3.60
47 2023-11-25 19.31 11.76 8.81 24.27 0.13 15.25 1.25 6.91 0.12 0.04 0.07 2.13 0.13 0.80 6.81 6.66 8.10 8.69 1.79 4.79
48 2023-12-02 18.03 12.12 11.62 24.04 0.19 18.07 0.76 9.40 0.26 0.03 0.15 3.18 0.08 1.20 6.99 6.87 8.92 9.47 3.11 6.08
49 2023-12-09 17.53 12.61 14.74 21.12 0.23 19.13 1.43 11.34 0.29 0.06 0.05 4.21 0.19 1.60 7.38 7.29 10.09 12.26 5.40 7.54
50 2023-12-16 17.78 13.10 15.32 17.31 0.23 26.42 1.97 13.93 0.36 0.06 0.02 7.50 0.15 2.48 7.26 8.61 10.78 13.19 6.42 8.55
51 2023-12-23 16.81 14.09 16.78 12.50 0.18 28.53 2.27 16.69 0.45 0.05 0.02 10.44 0.19 3.30 7.29 9.16 8.97 15.23 7.40 9.92
52 2023-12-30 15.35 15.53 18.18 7.93 0.09 33.97 3.30 20.32 0.52 0.07 0.01 12.58 0.23 4.04 7.41 10.59 6.72 17.80 7.89 10.97
1 2024-01-06 14.51 15.03 14.49 4.54 0.08 30.93 4.58 19.59 0.60 0.07 0.00 10.34 0.22 3.87 7.10 10.34 5.26 15.62 8.37 10.84
2 2024-01-13 13.03 13.38 11.16 2.21 0.11 26.80 5.46 19.11 0.56 0.05 0.01 11.01 0.29 3.91 6.26 9.07 4.32 14.05 7.45 10.24
3 2024-01-20 11.35 12.21 10.27 1.40 0.04 28.20 9.13 18.95 0.79 0.14 0.01 12.75 0.35 4.70 6.13 8.43 3.42 15.56 7.90 10.95
4 2024-01-27 10.19 11.30 11.10 0.91 0.05 27.01 12.34 18.82 1.08 0.14 0.00 12.74 0.41 5.17 5.85 7.96 2.33 15.88 8.38 11.89
5 2024-02-03 9.34 11.51 11.28 0.76 0.03 23.66 15.78 19.15 1.48 0.28 0.01 14.84 0.41 5.77 5.91 7.15 2.19 16.33 8.77 12.14
6 2024-02-10 8.79 11.88 10.37 0.67 0.04 23.36 15.68 18.80 1.74 0.34 0.01 16.23 0.44 6.22 5.21 5.78 2.10 15.79 7.98 12.32
7 2024-02-17 8.12 11.79 9.43 0.57 0.02 24.22 15.48 18.53 2.18 0.29 0.00 17.02 0.35 6.56 4.49 5.13 2.16 15.53 8.42 11.89
8 2024-02-24 7.49 11.73 8.01 0.57 0.06 28.62 12.42 18.57 3.17 0.49 0.02 16.79 0.45 6.61 4.78 4.53 2.12 15.47 8.04 11.28
9 2024-03-02 7.03 11.18 6.72 0.63 0.12 29.30 11.04 18.13 4.03 0.70 0.00 15.45 0.74 6.25 3.79 3.70 2.50 15.62 7.59 10.52
10 2024-03-09 6.24 11.41 5.55 0.63 0.16 29.65 8.51 16.84 5.12 0.77 0.00 14.86 0.81 6.42 3.64 2.80 3.10 14.97 6.92 9.92
11 2024-03-16 6.13 11.58 4.36 0.52 0.26 24.27 6.74 14.55 5.42 1.15 0.01 13.11 1.05 6.86 3.18 2.18 3.71 12.11 6.29 9.33
12 2024-03-23 5.17 11.28 3.30 0.59 0.86 20.91 5.51 12.68 5.82 1.29 0.00 11.53 1.51 7.43 2.49 1.98 3.79 10.70 6.46 8.59
13 2024-03-30 4.85 10.85 2.71 0.64 1.52 18.09 4.67 11.66 6.60 1.72 0.00 12.55 1.98 7.90 2.32 1.63 4.00 9.32 6.45 8.11
14 2024-04-06 4.74 10.91 2.28 0.38 2.48 24.10 3.21 11.23 6.70 1.84 0.01 13.12 2.14 7.89 2.05 1.33 4.05 8.09 6.06 6.91
Figure 2: Positive tests (%) of other respiratory viruses reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Figure 2

Shaded area represents the maximum and minimum % of respiratory virus tests positive reported by week from seasons 2014-2015 to 2019-2020

Note: Changes to testing practices during the COVID-19 pandemic may cause substantial changes to indicator estimates from previous years. Collection of laboratory testing practice meta-data to understand these changes is ongoing. Interpret trends with caution.

Note: Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Note: % Tests Positive scale changes across the dashed line

Figure 2: Positive tests (%) of other respiratory viruses reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Week Week end 2023-2024 EV/RV% 2022-2023 EV/RV% 2021-2022 EV/RV% Max EV/RV% Base Min EV/RV% Base Av EV/RV% Base 2023-2024 HPIV% 2022-2023 HPIV% 2021-2022 HPIV% Max HPIV% Base Min HPIV% Base Av HPIV% Base 2023-2024 ADV% 2022-2023 ADV% 2021-2022 ADV% Max ADV% Base Min ADV% Base Av ADV% Base 2023-2024 HMPV% 2022-2023 HMPV% 2021-2022 HMPV% Max HMPV% Base Min HMPV% Base Av HMPV% Base 2023-2024 HCoV% 2022-2023 HCoV% 2021-2022 HCoV% Max HCoV% Base Min HCoV% Base Av HCoV% Base
35 2023-09-02 12.50 15.47 21.96 27.19 22.44 24.71 1.99 2.80 5.99 3.16 1.15 2.44 1.62 2.28 1.18 1.74 0.99 1.43 0.34 1.80 0.23 2.04 0.10 0.78 0.28 0.53 1.05 0.76 0.18 0.45
36 2023-09-09 14.85 16.22 18.59 30.69 23.30 26.31 1.49 3.21 4.93 3.31 1.35 2.32 1.52 2.18 1.15 2.85 1.42 1.87 0.39 1.81 0.24 0.84 0.10 0.48 0.42 0.38 0.62 0.38 0.12 0.22
37 2023-09-16 18.29 21.73 27.46 33.58 27.74 31.69 1.60 3.02 5.97 3.26 1.65 2.40 1.47 2.10 0.81 2.44 1.38 1.86 0.39 1.38 0.17 1.61 0.00 0.51 0.23 0.28 0.44 0.56 0.00 0.26
38 2023-09-23 20.25 23.50 33.19 39.57 32.80 35.83 1.77 2.42 4.73 2.87 1.92 2.33 0.93 1.58 0.82 2.04 1.11 1.63 0.38 1.61 0.37 1.43 0.06 0.48 0.46 0.32 0.67 1.36 0.06 0.43
39 2023-09-30 18.52 22.89 30.01 40.59 34.87 37.68 1.32 3.09 8.12 3.01 1.70 2.24 1.15 2.21 1.14 2.27 1.04 1.66 0.51 1.43 0.17 0.72 0.05 0.29 0.28 0.59 0.62 0.66 0.07 0.45
40 2023-10-07 17.45 19.32 26.26 41.29 33.00 35.43 1.34 3.69 8.19 3.28 1.90 2.43 1.41 1.79 1.31 2.25 1.39 1.82 0.32 1.49 0.16 0.92 0.05 0.34 0.26 0.93 0.57 1.08 0.22 0.59
41 2023-10-14 15.74 16.70 22.91 33.62 26.94 29.93 1.28 3.52 10.46 3.70 1.96 2.75 1.38 2.03 1.37 1.91 1.28 1.70 0.37 1.66 0.20 0.95 0.04 0.46 0.32 0.99 1.69 0.70 0.00 0.34
42 2023-10-21 13.12 12.95 22.16 32.62 24.54 27.86 1.59 4.22 10.01 3.89 2.64 3.21 1.43 1.65 2.54 2.39 1.47 1.86 0.46 1.58 0.15 0.89 0.15 0.40 0.17 1.16 1.07 1.18 0.20 0.49
43 2023-10-28 12.52 11.05 19.64 28.73 21.67 24.95 1.21 4.41 9.38 3.98 3.18 3.54 1.48 1.79 1.15 2.42 1.63 1.96 0.46 1.79 0.36 1.64 0.12 0.58 0.38 1.86 1.05 2.35 0.27 0.75
44 2023-11-04 10.83 10.23 21.45 23.82 16.75 21.38 1.44 4.14 10.28 4.81 2.94 3.72 1.76 2.02 1.42 2.88 1.18 2.21 0.55 1.79 0.77 1.08 0.23 0.48 0.37 2.54 2.21 2.59 0.21 0.88
45 2023-11-11 10.70 7.77 22.39 23.08 15.17 20.56 1.65 3.90 9.97 5.42 2.53 4.01 1.45 1.99 1.63 2.68 2.02 2.42 0.60 2.06 0.64 1.30 0.04 0.77 0.42 3.00 2.57 2.74 0.52 0.96
46 2023-11-18 8.64 6.93 21.37 22.77 15.28 19.24 1.39 3.97 8.29 5.72 1.62 4.14 2.03 1.87 2.51 2.90 1.99 2.52 0.79 1.89 0.99 1.43 0.18 0.81 0.65 3.54 2.99 3.32 0.46 1.25
47 2023-11-25 7.62 4.88 18.54 20.84 12.15 16.09 1.55 3.63 7.04 7.00 2.36 4.72 1.90 1.89 1.94 2.95 1.83 2.35 1.00 1.78 1.01 2.02 0.09 0.90 0.65 3.24 3.90 3.26 0.37 1.25
48 2023-12-02 6.79 4.74 16.64 16.72 12.69 13.84 1.51 3.04 5.78 6.14 3.03 4.18 2.15 1.87 1.89 3.34 1.66 2.49 0.91 1.86 1.48 1.94 0.31 1.09 0.76 3.94 4.94 4.30 1.00 2.04
49 2023-12-09 6.00 4.09 14.57 16.32 10.72 13.07 1.39 3.03 3.97 5.65 2.94 4.19 1.83 1.68 2.48 3.03 1.84 2.50 1.20 1.93 1.22 2.80 0.49 1.48 1.12 4.48 6.58 5.19 0.84 2.53
50 2023-12-16 5.90 4.58 12.40 13.85 8.43 10.91 1.46 2.98 3.23 5.95 2.54 4.22 2.00 2.29 2.72 3.13 1.49 2.42 1.31 1.92 1.08 3.32 0.46 1.68 1.47 5.13 7.26 6.04 1.54 3.16
51 2023-12-23 5.56 4.49 9.95 14.18 8.81 10.48 1.35 3.09 3.01 6.71 2.94 3.95 1.55 1.76 2.54 3.20 1.36 2.04 1.59 2.23 1.20 4.39 0.37 2.47 1.77 5.28 8.11 6.68 1.87 3.72
52 2023-12-30 4.71 4.50 7.71 14.41 6.24 9.26 1.35 3.32 2.13 5.08 2.87 3.75 1.76 1.80 1.92 2.59 1.20 1.76 1.76 2.75 1.00 3.81 0.41 2.49 2.48 4.73 10.33 6.73 2.78 4.73
1 2024-01-06 4.80 4.19 5.71 11.09 4.36 7.42 1.48 3.63 1.84 5.08 2.68 3.34 1.48 1.88 1.84 2.67 0.85 1.54 2.20 2.94 0.72 4.45 0.28 2.74 3.06 4.40 9.27 7.77 3.07 5.16
2 2024-01-13 4.43 4.71 3.98 9.55 4.31 6.79 1.17 3.24 1.19 4.12 2.46 3.05 1.25 1.87 1.13 2.15 0.87 1.37 1.64 2.61 0.38 4.76 0.42 2.69 3.19 4.01 7.46 7.89 2.84 5.45
3 2024-01-20 4.59 6.68 3.12 8.42 4.44 6.01 1.08 2.92 0.76 3.25 2.59 2.82 1.11 1.97 1.34 2.10 1.15 1.45 2.20 2.56 0.24 5.56 0.47 3.18 3.89 3.46 4.97 7.90 4.17 6.11
4 2024-01-27 4.37 8.22 2.60 9.04 4.89 6.41 1.16 2.78 0.64 3.12 1.77 2.55 1.56 2.35 1.18 1.83 1.11 1.49 2.11 2.71 0.23 5.19 0.55 3.05 5.19 2.63 3.92 7.86 3.79 6.09
5 2024-02-03 5.02 8.94 3.02 9.79 6.06 6.94 1.45 2.70 0.48 3.48 1.70 2.39 1.62 2.44 1.57 1.93 1.36 1.62 2.27 2.96 0.25 5.70 0.58 3.34 5.10 3.20 2.83 8.49 4.55 6.84
6 2024-02-10 6.26 9.97 3.86 9.89 6.16 6.98 1.56 2.68 0.51 2.89 1.57 2.19 1.84 2.14 1.44 1.74 1.25 1.51 2.54 3.73 0.42 5.57 0.65 3.48 6.80 2.64 3.01 8.57 3.48 6.75
7 2024-02-17 6.18 9.87 4.46 8.95 6.00 7.04 1.54 2.63 0.44 3.20 1.42 2.11 1.22 2.31 1.52 1.61 1.30 1.51 2.82 4.41 0.44 6.05 1.45 3.96 7.73 3.14 3.24 8.02 4.35 6.52
8 2024-02-24 6.21 9.55 6.31 8.35 5.20 6.94 1.84 2.55 0.73 3.21 1.31 2.25 1.30 2.86 1.85 2.00 1.38 1.66 3.15 4.29 0.53 5.74 1.19 4.19 8.28 3.07 3.67 8.29 4.21 6.61
9 2024-03-02 6.48 9.77 7.80 9.03 5.73 7.75 2.40 3.07 0.60 3.35 1.41 2.44 1.65 2.75 1.90 1.92 1.09 1.40 3.92 4.72 0.40 6.42 1.87 4.46 7.09 3.41 3.32 8.01 5.09 6.87
10 2024-03-09 6.52 9.42 8.24 10.16 5.53 8.08 2.74 2.77 0.68 4.18 1.19 2.69 1.31 2.79 1.98 2.23 1.50 1.78 4.57 5.05 0.51 6.74 2.26 4.94 6.84 3.71 3.86 8.34 4.28 6.99
11 2024-03-16 6.67 8.77 8.97 9.45 7.15 8.22 3.43 3.48 0.66 4.58 1.35 3.00 1.29 2.39 1.88 2.32 1.23 1.69 4.88 5.07 0.59 7.94 2.52 4.87 7.18 3.70 3.25 8.02 4.35 6.23
12 2024-03-23 6.63 9.31 9.52 10.26 8.58 9.63 4.10 2.98 1.05 4.95 1.26 3.33 1.42 2.60 1.71 2.13 1.82 1.96 4.63 5.40 0.77 6.69 3.65 5.35 6.79 4.50 4.38 6.99 3.95 5.67
13 2024-03-30 7.37 8.35 8.49 12.58 7.69 10.26 4.53 3.17 1.39 5.21 1.48 3.68 1.63 2.51 2.30 2.12 1.37 1.70 5.02 4.79 1.28 6.90 3.95 5.27 6.01 4.04 4.45 8.16 3.65 5.46
14 2024-04-06 7.39 8.95 9.25 13.59 8.46 12.00 4.46 3.45 1.18 6.26 1.67 4.30 1.54 2.56 1.74 2.31 1.50 1.86 5.19 4.61 1.45 7.70 4.14 5.99 6.71 4.51 4.24 7.79 3.84 4.86

Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests

Figure 3: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (%) in Canada by region by surveillance week
Figure 3

Note: Differences in positivity between jurisdictions can reflect differences in testing practices. Please interpret with caution.

Figure 3: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (%) in Canada by region by surveillance week
Week Week end Can Tests SARS-CoV-2% Atl Tests SARS-CoV-2% QC Tests SARS-CoV-2% ON Tests SARS-CoV-2% Pr Tests SARS-CoV-2% BC Tests SARS-CoV-2% Terr Tests SARS-CoV-2%
35 2023-09-02 25656 14.40 2110 16.92 9351 16.30 6230 12.39 5192 10.59 2651 18.03 122 11.48
36 2023-09-09 28237 15.92 2346 20.20 10215 17.37 6939 15.46 5968 11.90 2640 16.70 129 17.05
37 2023-09-16 31790 16.49 2567 18.62 11678 18.11 7337 15.66 6948 12.12 3111 20.64 149 10.07
38 2023-09-23 36264 18.60 2775 18.38 13455 20.48 8514 18.38 7969 14.23 3377 22.59 174 10.34
39 2023-09-30 40587 19.59 3126 22.65 15431 21.30 9291 17.86 8658 15.65 3895 23.59 186 12.90
40 2023-10-07 42173 19.81 3544 24.41 15684 22.19 9349 17.61 9198 15.96 4202 20.75 196 12.24
41 2023-10-14 38462 17.55 3583 20.74 12605 18.30 8426 15.27 9624 16.76 4047 19.13 177 14.69
42 2023-10-21 39350 17.78 3493 19.70 12590 18.63 9300 16.86 10040 17.16 3737 17.13 190 17.37
43 2023-10-28 37286 17.89 3095 17.74 12003 18.29 9276 19.35 9450 17.05 3262 14.87 200 17.50
44 2023-11-04 38183 17.74 2965 17.91 11975 18.42 9060 17.09 10341 18.12 3648 15.98 194 15.98
45 2023-11-11 38722 18.17 3122 20.12 11815 19.90 9607 18.24 10448 16.98 3545 14.41 185 10.81
46 2023-11-18 41432 18.80 3186 22.47 13182 20.21 10470 20.36 11134 16.80 3245 12.14 215 5.12
47 2023-11-25 42304 19.31 3490 22.35 12938 21.52 10880 22.17 11422 15.57 3385 11.96 189 6.35
48 2023-12-02 44713 18.03 3648 21.98 14100 22.18 11174 20.06 11903 12.58 3639 10.31 249 7.63
49 2023-12-09 46876 17.53 3654 20.17 14467 22.78 11644 18.67 12452 12.41 4272 10.30 387 6.98
50 2023-12-16 48215 17.78 4065 18.60 15835 23.97 12142 18.69 12089 11.16 3746 10.25 338 6.21
51 2023-12-23 48372 16.81 4353 15.81 16682 22.12 11548 18.73 11472 9.91 3952 10.55 365 9.86
52 2023-12-30 46997 15.35 4234 14.67 15739 19.65 11522 17.68 10314 9.95 4930 8.64 258 5.04
1 2024-01-06 48060 14.51 4471 12.68 15874 17.71 11545 16.83 10577 10.62 5300 9.57 293 7.17
2 2024-01-13 44189 13.03 4333 11.98 13921 14.75 11346 14.29 9475 9.91 4862 12.48 252 6.35
3 2024-01-20 38190 11.35 3750 10.64 11599 11.60 9942 12.87 8591 9.92 4141 10.92 167 4.19
4 2024-01-27 37089 10.19 3784 9.49 11052 9.79 9238 11.40 8358 8.95 4459 11.89 198 4.04
5 2024-02-03 36771 9.34 3908 8.75 10995 8.58 9011 9.75 8265 9.56 4420 10.63 172 5.81
6 2024-02-10 34740 8.79 3499 8.80 10544 7.33 8519 8.48 8042 10.12 3940 10.74 196 7.14
7 2024-02-17 35098 8.12 3185 8.92 11071 6.64 8901 7.48 8021 9.21 3722 11.04 198 7.07
8 2024-02-24 34145 7.49 3098 8.23 10925 5.10 8077 6.82 7890 8.66 3872 12.45 283 10.25
9 2024-03-02 33779 7.03 2992 7.02 10468 4.88 8299 6.21 7831 8.42 3972 11.76 217 6.45
10 2024-03-09 32484 6.24 3112 7.42 9479 3.46 7884 4.67 7845 7.71 3860 12.31 304 6.25
11 2024-03-16 32416 6.13 3346 6.90 9376 3.03 7702 5.47 7795 7.36 3904 11.63 293 7.51
12 2024-03-23 30991 5.17 3206 7.74 8609 2.25 7772 4.26 7547 6.15 3552 9.80 305 5.25
13 2024-03-30 29574 4.85 2831 6.85 8540 2.69 6962 4.28 7517 4.98 3452 9.24 272 7.35
14 2024-04-06 28886 4.74 2964 6.01 8709 2.38 6428 4.70 7205 4.48 3308 10.46 272 4.78

Positive influenza (Flu) tests

Figure 4: Positive influenza (Flu) tests (%) in Canada by region by surveillance week
Figure 4
Figure 4: Positive influenza (Flu) tests (%) in Canada by region by surveillance week
Week Week end Can Tests Can A% Can B% Atl Tests Atl A% Atl B% QC Tests QC A% QC B% ON Tests ON A% ON B% Pr Tests Pr A% Pr B% BC Tests BC A% BC B% Terr Tests Terr A% Terr B%
35 2023-09-02 14543 0.69 0.06 984 0.00 0.00 3339 0.24 0.15 4324 0.39 0.09 3654 0.57 0.00 2158 2.46 0.00 84 2.38 0.00
36 2023-09-09 15430 0.43 0.06 1047 0.00 0.00 3649 0.19 0.03 4455 0.31 0.09 4069 0.37 0.05 2117 1.46 0.09 93 0.00 0.00
37 2023-09-16 18035 0.48 0.03 1216 0.08 0.00 4174 0.41 0.07 5145 0.29 0.00 4705 0.40 0.04 2703 1.29 0.04 92 0.00 0.00
38 2023-09-23 20121 0.51 0.02 1388 0.07 0.00 4734 0.30 0.00 5652 0.21 0.05 5325 0.62 0.02 2928 1.47 0.00 94 0.00 0.00
39 2023-09-30 21530 0.51 0.09 1403 0.14 0.07 4847 0.21 0.08 6186 0.37 0.11 5371 0.48 0.11 3598 1.36 0.06 125 0.00 0.00
40 2023-10-07 23658 0.64 0.05 1775 0.34 0.00 5628 0.37 0.04 6456 0.31 0.00 5803 0.74 0.16 3878 1.60 0.05 118 0.00 0.00
41 2023-10-14 23208 0.49 0.03 1938 0.57 0.00 4978 0.22 0.06 6283 0.30 0.00 6067 0.73 0.05 3828 0.73 0.03 114 0.00 0.00
42 2023-10-21 24067 0.73 0.08 2029 0.69 0.05 5110 0.37 0.02 6834 0.47 0.07 6370 1.13 0.13 3599 1.06 0.11 125 0.00 0.00
43 2023-10-28 23268 1.16 0.10 1979 0.96 0.00 5450 0.64 0.11 6814 0.50 0.06 5872 2.33 0.17 3039 1.45 0.10 114 0.88 0.00
44 2023-11-04 25317 2.63 0.10 1914 1.25 0.05 5705 0.63 0.07 6996 0.51 0.06 6996 6.80 0.17 3562 2.58 0.11 144 2.08 0.00
45 2023-11-11 26520 4.93 0.14 2069 2.03 0.14 5970 0.84 0.07 7240 1.22 0.07 7656 12.87 0.26 3460 3.96 0.14 125 4.00 0.00
46 2023-11-18 28583 7.24 0.16 2219 3.11 0.09 6454 1.36 0.09 7797 2.68 0.15 8734 18.14 0.26 3258 3.59 0.12 121 2.48 0.00
47 2023-11-25 29879 8.81 0.12 2521 4.60 0.04 6561 2.04 0.06 8070 2.69 0.02 9078 21.15 0.28 3517 6.43 0.09 132 15.15 0.00
48 2023-12-02 32859 11.62 0.26 2743 4.89 0.11 7199 3.78 0.15 8447 4.45 0.17 10485 24.44 0.47 3836 10.79 0.21 149 38.93 0.00
49 2023-12-09 34573 14.74 0.29 2817 9.66 0.11 8141 7.14 0.12 8466 7.08 0.21 11298 26.93 0.57 3590 13.12 0.11 261 49.81 0.00
50 2023-12-16 38612 15.32 0.36 3363 12.73 0.09 10087 11.63 0.12 9265 8.47 0.41 11116 24.56 0.71 4496 14.23 0.16 285 56.49 0.00
51 2023-12-23 40839 16.78 0.45 3820 19.08 0.31 12090 15.38 0.12 9246 11.39 0.51 10656 21.67 0.91 4747 16.64 0.29 280 40.36 0.00
52 2023-12-30 42482 18.18 0.52 3874 20.99 0.36 13501 19.37 0.07 9830 15.02 0.63 9720 17.61 1.26 5352 18.89 0.24 205 46.34 0.00
1 2024-01-06 43260 14.49 0.60 4132 17.91 0.36 13858 17.30 0.22 9869 11.67 0.54 9519 11.29 1.45 5634 14.55 0.39 248 33.47 0.00
2 2024-01-13 40233 11.16 0.56 3864 15.79 0.31 12702 15.32 0.19 9980 9.08 0.59 8491 5.94 1.33 4963 9.83 0.32 233 15.88 0.43
3 2024-01-20 35213 10.27 0.79 3422 14.23 0.94 11099 14.72 0.36 8812 8.65 0.45 7343 4.09 2.07 4397 9.71 0.34 140 5.71 0.00
4 2024-01-27 35174 11.10 1.08 3461 14.59 1.36 11277 17.65 0.28 8274 8.87 0.59 7261 2.31 2.91 4722 10.67 0.87 179 2.79 0.00
5 2024-02-03 35522 11.28 1.48 3608 14.61 2.02 12036 19.09 0.61 7738 8.30 1.02 7380 1.91 3.20 4626 8.58 1.25 134 2.24 2.99
6 2024-02-10 33997 10.37 1.74 3230 12.38 1.98 11857 18.01 1.05 7402 7.23 1.50 7230 1.77 3.28 4119 7.99 1.24 159 0.00 3.14
7 2024-02-17 33917 9.43 2.18 2882 8.78 2.74 11966 16.61 1.53 7689 7.40 1.87 7229 1.58 3.62 4006 6.81 1.40 145 1.38 11.03
8 2024-02-24 33294 8.01 3.17 2914 7.41 2.88 11748 14.22 2.63 7189 6.37 2.35 7030 1.07 5.65 4225 5.80 1.82 188 0.53 9.57
9 2024-03-02 32543 6.72 4.03 2834 7.13 4.13 11373 10.92 4.28 7133 5.72 2.90 6806 1.59 5.80 4231 5.25 1.96 166 2.41 13.25
10 2024-03-09 31700 5.55 5.12 2826 7.01 6.37 10775 8.84 5.27 6873 4.89 4.09 6835 1.29 6.63 4160 4.33 2.81 231 2.16 9.96
11 2024-03-16 30555 4.36 5.42 3170 6.03 4.95 9835 6.05 5.63 6948 3.94 3.80 6297 1.46 8.15 4077 4.42 3.63 228 0.44 8.77
12 2024-03-23 30633 3.30 5.82 3097 4.91 5.97 9578 3.82 5.54 6960 3.30 3.39 6918 1.45 9.35 3820 4.08 3.46 260 3.08 19.62
13 2024-03-30 29847 2.71 6.60 2909 3.82 7.25 9562 3.50 6.67 6384 2.44 3.29 7085 1.30 10.50 3679 3.07 3.07 228 0.88 23.25
14 2024-04-06 29070 2.28 6.70 2945 2.51 7.13 9679 2.56 8.14 6182 2.67 3.41 6692 1.48 9.10 3351 2.24 2.89 221 0.45 15.38

Positive respiratory syncytial virus (RSV) tests

Figure 5: Positive respiratory syncytial virus (RSV) tests (%) in Canada by region by surveillance week
Figure 5
Figure 5: Positive respiratory syncytial virus (RSV) tests (%) in Canada by region by surveillance week
Week Week end Can Tests RSV% Atl Tests RSV% QC Tests RSV% ON Tests RSV% Pr Tests RSV% BC Tests RSV% Terr Tests RSV%
35 2023-09-02 13610 0.58 969 0.00 2540 1.14 4324 0.81 3535 0.20 2158 0.32 84 1.19
36 2023-09-09 14361 0.71 1047 0.57 2750 1.64 4455 0.88 3915 0.18 2101 0.24 93 0.00
37 2023-09-16 16808 0.82 1201 0.25 3181 1.67 5138 1.01 4494 0.38 2702 0.41 92 1.09
38 2023-09-23 18782 1.15 1381 1.30 3652 2.27 5652 1.43 5075 0.37 2928 0.51 94 0.00
39 2023-09-30 20217 1.14 1392 0.79 3788 2.38 6186 1.42 5128 0.43 3598 0.56 125 0.00
40 2023-10-07 22042 1.35 1761 0.28 4333 2.75 6456 1.95 5496 0.36 3878 0.72 118 0.00
41 2023-10-14 21748 1.80 1927 0.83 3897 3.70 6281 2.48 5701 0.63 3828 1.04 114 0.00
42 2023-10-21 22479 2.38 2015 0.69 3889 4.78 6834 3.72 6017 0.58 3599 1.25 125 0.00
43 2023-10-28 21745 3.25 1970 1.78 4234 6.24 6814 4.21 5574 1.22 3039 1.74 114 0.00
44 2023-11-04 23657 4.07 1904 2.15 4506 6.88 6997 5.80 6544 1.79 3562 2.36 144 2.78
45 2023-11-11 24764 5.12 2058 2.77 4680 7.97 7241 7.62 7201 2.14 3459 3.58 125 6.40
46 2023-11-18 26517 5.85 2195 2.41 4910 10.14 7796 7.91 8237 2.87 3258 4.27 121 7.44
47 2023-11-25 27491 6.81 2363 4.70 4975 11.82 8068 8.66 8508 3.24 3445 5.28 132 11.36
48 2023-12-02 30258 6.99 2549 5.88 5533 11.46 8447 8.49 9797 3.57 3783 6.66 149 8.72
49 2023-12-09 31232 7.38 2665 7.69 5930 11.11 8465 7.40 10436 4.53 3475 9.35 261 6.90
50 2023-12-16 34607 7.26 3004 8.46 7537 9.73 9261 5.99 10173 5.17 4347 9.50 285 10.53
51 2023-12-23 35988 7.29 3258 9.45 8774 9.14 9244 4.64 9820 6.47 4615 9.36 277 6.14
52 2023-12-30 37639 7.41 3431 8.57 9849 7.53 9829 4.62 9130 8.48 5196 9.49 204 15.69
1 2024-01-06 37934 7.10 3630 9.12 9953 7.31 9871 4.03 8828 7.56 5404 9.88 248 13.71
2 2024-01-13 35286 6.26 3383 9.16 9029 6.14 9975 3.27 7930 7.65 4737 7.81 232 17.67
3 2024-01-20 30827 6.13 2936 9.91 7837 5.82 8808 2.99 6892 8.21 4214 6.76 140 20.00
4 2024-01-27 30616 5.85 3067 10.01 7786 5.48 8260 2.62 6810 6.83 4514 7.35 179 24.02
5 2024-02-03 30446 5.91 3235 9.52 7985 5.07 7736 2.12 6932 8.18 4426 7.32 132 24.24
6 2024-02-10 29075 5.21 2949 10.07 7832 4.60 7404 1.62 6794 6.74 3937 6.27 159 20.75
7 2024-02-17 29028 4.49 2610 8.12 7969 4.56 7689 1.16 6769 6.04 3846 4.91 145 27.59
8 2024-02-24 28917 4.78 2715 7.18 8169 4.55 7189 1.14 6600 6.83 4057 5.57 187 29.41
9 2024-03-02 28626 3.79 2712 6.42 8150 3.99 7134 1.23 6368 4.35 4096 4.32 166 26.51
10 2024-03-09 27634 3.64 2700 6.52 7381 4.09 6873 0.89 6407 3.59 4043 3.96 230 33.91
11 2024-03-16 26585 3.18 3019 5.13 6559 3.58 6948 0.88 5896 3.43 3935 3.66 228 21.05
12 2024-03-23 26748 2.49 2944 3.53 6480 3.33 6961 0.49 6396 2.94 3707 2.81 260 7.69
13 2024-03-30 26064 2.32 2642 3.14 6610 3.77 6384 0.58 6647 2.20 3553 1.83 228 10.96
14 2024-04-06 25327 2.05 2685 2.76 6707 2.98 6182 0.61 6272 1.95 3260 2.06 221 7.69

Positive human parainfluenza virus (HPIV) tests

Figure 6: Positive human parainfluenza virus (HPIV) tests (%) in Canada by region by surveillance week
Figure 6
Figure 6: Positive human parainfluenza virus (HPIV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HPIV% Atl Tests HPIV% QC Tests HPIV% ON Tests HPIV% Pr Tests HPIV% BC Tests HPIV%
35 2023-09-02 6234 1.99 362 1.38 847 3.90 3406 1.85 984 1.02 635 2.05
36 2023-09-09 6321 1.49 355 1.69 868 2.19 3420 1.43 1133 0.97 545 1.65
37 2023-09-16 7419 1.60 401 2.49 1053 2.18 3886 1.34 1326 1.06 753 2.66
38 2023-09-23 8139 1.77 430 2.79 1122 2.85 4366 1.74 1445 0.90 776 1.42
39 2023-09-30 8627 1.32 401 1.25 1117 1.88 4948 1.33 1415 1.06 746 0.94
40 2023-10-07 8791 1.34 467 3.43 1178 2.04 4850 1.20 1541 0.39 755 1.85
41 2023-10-14 8879 1.28 491 1.63 1094 1.37 4898 1.16 1638 1.04 758 2.24
42 2023-10-21 9281 1.59 498 2.21 1050 1.52 5293 1.51 1707 1.46 733 2.18
43 2023-10-28 9085 1.21 474 1.48 1063 1.98 5223 0.96 1656 0.85 669 2.69
44 2023-11-04 9496 1.44 492 2.24 1067 2.06 5215 1.00 1938 1.24 784 3.57
45 2023-11-11 9826 1.65 467 2.78 1257 1.83 5242 1.11 2076 1.35 784 5.10
46 2023-11-18 10441 1.39 500 2.20 1426 1.33 5505 1.24 2191 0.87 819 3.42
47 2023-11-25 10872 1.55 620 1.77 1442 1.04 5708 1.47 2195 1.18 907 3.53
48 2023-12-02 11676 1.51 676 2.37 1587 1.32 5967 1.39 2463 1.10 983 2.95
49 2023-12-09 11621 1.39 668 1.65 1630 1.10 6040 1.44 2537 1.14 746 2.14
50 2023-12-16 12631 1.46 730 1.92 1664 0.72 6696 1.36 2459 1.46 1082 2.96
51 2023-12-23 12648 1.35 768 1.56 1857 0.54 6421 1.46 2408 0.79 1194 3.02
52 2023-12-30 12871 1.35 709 1.55 2004 0.85 6809 1.29 2168 0.97 1181 3.13
1 2024-01-06 13434 1.48 812 1.72 2046 0.59 7059 1.60 2288 1.18 1229 2.69
2 2024-01-13 13182 1.17 924 1.73 1882 0.53 7137 1.16 2111 1.09 1128 1.95
3 2024-01-20 11423 1.08 704 1.28 1843 0.49 6099 1.18 1774 1.13 1003 1.30
4 2024-01-27 11007 1.16 834 0.72 1793 0.28 5677 1.41 1707 1.41 996 1.31
5 2024-02-03 11179 1.45 794 1.26 1833 0.55 5534 1.66 1933 1.86 1085 1.29
6 2024-02-10 10714 1.56 782 0.77 1832 0.49 5194 1.73 1937 1.55 969 3.30
7 2024-02-17 10731 1.54 619 1.29 1863 0.54 5369 1.42 1898 2.32 982 2.75
8 2024-02-24 10455 1.84 632 0.47 1825 1.59 5114 1.82 1905 2.20 979 2.55
9 2024-03-02 10419 2.40 587 1.02 1800 1.11 5157 2.83 1793 2.90 1082 2.40
10 2024-03-09 9897 2.74 483 2.69 1681 1.84 4982 2.65 1749 3.66 1002 3.09
11 2024-03-16 9750 3.43 626 1.92 1433 1.88 5071 3.45 1624 4.99 996 3.92
12 2024-03-23 9990 4.10 592 3.21 1588 2.33 5076 4.10 1810 4.92 924 6.17
13 2024-03-30 9390 4.53 581 3.96 1540 3.70 4578 4.59 1766 4.70 925 5.62
14 2024-04-06 9246 4.46 597 4.69 1632 3.25 4630 4.38 1597 5.20 790 5.70

Positive adenovirus (ADV) tests

Figure 7: Positive adenovirus (ADV) tests (%) in Canada by region by surveillance week
Figure 7
Figure 7: Positive adenovirus (ADV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests ADV% Atl Tests ADV% QC Tests ADV% ON Tests ADV% Pr Tests ADV% BC Tests ADV%
35 2023-09-02 6238 1.62 362 1.93 851 2.70 3406 0.91 984 2.44 635 2.52
36 2023-09-09 6332 1.52 355 1.97 879 2.28 3420 0.82 1133 2.03 545 3.30
37 2023-09-16 7438 1.47 401 2.00 1071 2.43 3887 0.90 1326 1.96 753 1.86
38 2023-09-23 8149 0.93 429 1.17 1134 1.06 4365 0.62 1445 1.59 776 1.16
39 2023-09-30 8614 1.15 401 1.00 1129 2.04 4923 0.69 1415 1.63 746 2.01
40 2023-10-07 8809 1.41 467 2.36 1195 2.85 4851 0.66 1541 1.69 755 2.78
41 2023-10-14 8913 1.38 491 1.63 1111 3.42 4915 0.75 1638 1.47 758 2.11
42 2023-10-21 9286 1.43 498 1.20 1058 3.59 5292 0.76 1705 1.47 733 3.27
43 2023-10-28 9099 1.48 474 2.74 1077 3.62 5223 0.69 1656 1.63 669 2.99
44 2023-11-04 9514 1.76 492 2.03 1085 3.87 5215 1.04 1938 2.12 784 2.55
45 2023-11-11 9843 1.45 467 2.57 1274 2.98 5242 0.92 2076 1.64 784 1.40
46 2023-11-18 10452 2.03 500 4.60 1437 4.31 5505 0.94 2191 1.92 819 4.03
47 2023-11-25 10920 1.90 620 2.74 1461 3.97 5712 1.07 2194 1.50 911 3.84
48 2023-12-02 11737 2.15 676 3.25 1613 3.84 5967 1.36 2462 2.03 983 3.05
49 2023-12-09 11699 1.83 668 2.84 1652 3.75 6041 1.18 2537 1.26 746 3.62
50 2023-12-16 12719 2.00 730 2.19 1681 3.09 6696 1.78 2459 1.67 1082 2.40
51 2023-12-23 12035 1.55 768 1.82 1875 2.61 5726 0.89 2408 1.45 1194 3.02
52 2023-12-30 10983 1.76 709 2.12 2010 2.49 4852 0.80 2167 1.43 1181 4.74
1 2024-01-06 11675 1.48 812 1.11 2050 2.20 5219 0.75 2288 1.14 1229 4.15
2 2024-01-13 12078 1.25 924 1.52 1901 2.31 5943 0.59 2111 1.33 1126 2.49
3 2024-01-20 11461 1.11 704 1.56 1851 1.19 6091 0.64 1774 1.35 1003 2.89
4 2024-01-27 11062 1.56 834 2.88 1807 2.32 5675 0.78 1706 1.64 996 3.41
5 2024-02-03 11223 1.62 794 2.90 1841 2.55 5534 0.74 1933 1.55 1085 3.59
6 2024-02-10 10761 1.84 782 3.45 1852 2.59 5192 0.67 1935 1.45 969 5.88
7 2024-02-17 10779 1.22 619 1.29 1875 1.97 5369 0.60 1898 1.16 982 2.95
8 2024-02-24 10525 1.30 632 2.06 1837 2.01 5114 0.80 1905 0.89 979 2.96
9 2024-03-02 10484 1.65 587 4.26 1822 2.25 5157 1.01 1793 1.06 1082 2.87
10 2024-03-09 9989 1.31 483 1.86 1708 1.70 4982 0.78 1748 1.54 1002 2.30
11 2024-03-16 9808 1.29 626 1.44 1458 1.99 5072 0.79 1623 1.48 996 2.41
12 2024-03-23 10056 1.42 592 1.35 1614 1.49 5076 1.18 1809 1.00 924 3.46
13 2024-03-30 9438 1.63 581 2.07 1565 3.07 4578 0.87 1766 0.96 925 4.00
14 2024-04-06 9296 1.54 597 2.01 1647 3.04 4630 0.73 1597 0.88 790 4.05

Positive human metapneumovirus (HMPV) tests

Figure 8: Positive human metapneumovirus (HMPV) tests (%) in Canada by region by surveillance week
Figure 8
Figure 8: Positive human metapneumovirus (HMPV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HMPV% Atl Tests HMPV% QC Tests HMPV% ON Tests HMPV% Pr Tests HMPV% BC Tests HMPV%
35 2023-09-02 6260 0.34 362 0.00 848 1.42 3407 0.21 1008 0.10 635 0.16
36 2023-09-09 6354 0.39 355 0.28 867 1.38 3423 0.20 1164 0.26 545 0.37
37 2023-09-16 7455 0.39 401 0.50 1053 0.76 3886 0.36 1362 0.07 753 0.53
38 2023-09-23 8194 0.38 429 0.00 1124 1.07 4365 0.14 1500 0.13 776 1.42
39 2023-09-30 8680 0.51 401 0.25 1118 0.89 4948 0.36 1467 0.34 746 1.34
40 2023-10-07 8828 0.32 457 0.44 1180 0.76 4853 0.14 1583 0.32 755 0.66
41 2023-10-14 8911 0.37 484 0.00 1096 1.00 4915 0.20 1658 0.12 758 1.32
42 2023-10-21 9321 0.46 498 0.20 1050 1.33 5298 0.32 1742 0.17 733 1.09
43 2023-10-28 9083 0.46 474 0.63 1066 1.41 5200 0.31 1674 0.18 669 0.75
44 2023-11-04 9519 0.55 492 0.20 1070 1.96 5218 0.17 1955 0.61 784 1.15
45 2023-11-11 9825 0.60 467 0.21 1256 2.15 5244 0.21 2074 0.63 784 0.89
46 2023-11-18 10315 0.79 500 0.40 1426 2.38 5505 0.36 2180 0.37 704 2.56
47 2023-11-25 10920 1.00 620 0.97 1442 2.57 5715 0.44 2210 0.59 911 2.96
48 2023-12-02 11703 0.91 676 0.89 1585 2.33 5965 0.47 2458 0.49 983 2.34
49 2023-12-09 11654 1.20 668 1.20 1635 2.39 6037 0.61 2513 1.95 746 0.94
50 2023-12-16 12683 1.31 730 1.78 1669 2.52 6707 0.63 2424 1.61 1082 2.77
51 2023-12-23 12659 1.59 768 1.56 1857 2.48 6415 0.78 2361 2.50 1194 2.85
52 2023-12-30 12881 1.76 709 2.26 2006 2.14 6809 0.98 2112 2.27 1181 4.49
1 2024-01-06 13431 2.20 812 1.85 2048 2.15 7012 1.07 2253 3.99 1229 5.78
2 2024-01-13 13207 1.64 924 1.41 1887 1.59 7144 0.62 2053 3.85 1126 4.26
3 2024-01-20 11426 2.20 704 1.56 1837 2.34 6103 1.23 1741 4.19 1003 4.79
4 2024-01-27 11026 2.11 834 1.92 1793 1.78 5678 1.13 1681 4.34 996 4.82
5 2024-02-03 11160 2.27 794 2.39 1831 2.46 5534 1.36 1880 2.87 1085 5.44
6 2024-02-10 10709 2.54 782 2.94 1828 2.63 5191 1.58 1908 2.62 969 7.12
7 2024-02-17 10757 2.82 619 2.91 1864 3.70 5376 2.14 1880 1.91 982 6.62
8 2024-02-24 10425 3.15 632 3.96 1825 2.79 5113 2.62 1818 2.31 979 7.76
9 2024-03-02 10398 3.92 587 3.75 1802 4.99 5157 3.37 1727 2.49 1082 7.30
10 2024-03-09 9915 4.57 483 5.38 1677 5.66 4991 4.49 1696 1.83 1002 7.58
11 2024-03-16 9742 4.88 626 7.67 1433 5.65 5084 4.76 1570 2.04 996 7.13
12 2024-03-23 9948 4.63 592 5.57 1589 5.48 5085 4.90 1717 1.75 924 6.71
13 2024-03-30 9325 5.02 581 7.40 1536 6.90 4589 4.73 1671 1.62 925 8.11
14 2024-04-06 9222 5.19 597 7.54 1631 6.62 4634 5.55 1535 1.43 790 5.82

Positive enterovirus/rhinovirus (EV/RV) tests

Figure 9: Positive enterovirus/rhinovirus (EV/RV) tests (%) in Canada by region by surveillance week
Figure 9
Figure 9: Positive enterovirus/rhinovirus (EV/RV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests EV/RV% Atl Tests EV/RV% QC Tests EV/RV% ON Tests EV/RV% Pr Tests EV/RV% BC Tests EV/RV%
35 2023-09-02 5345 12.50 362 20.72 - - 3409 10.44 966 14.60 608 15.79
36 2023-09-09 5414 14.85 355 25.35 - - 3423 12.80 1119 16.80 516 17.05
37 2023-09-16 6331 18.29 401 23.69 - - 3887 16.08 1314 22.37 722 19.81
38 2023-09-23 6991 20.25 429 27.51 - - 4365 17.11 1428 25.14 747 24.63
39 2023-09-30 7479 18.52 401 26.43 - - 4948 15.74 1398 22.17 715 25.31
40 2023-10-07 7559 17.45 467 23.55 - - 4853 14.77 1515 20.99 706 23.80
41 2023-10-14 7762 15.74 491 23.01 - - 4915 13.77 1612 16.00 717 23.15
42 2023-10-21 8204 13.12 498 22.09 - - 5298 10.82 1681 13.50 695 22.16
43 2023-10-28 7977 12.52 474 16.03 - - 5227 9.95 1624 15.58 637 23.23
44 2023-11-04 8385 10.83 492 17.07 - - 5218 8.39 1916 12.21 736 20.52
45 2023-11-11 8530 10.70 467 16.70 - - 5244 8.68 2051 10.48 743 21.53
46 2023-11-18 8958 8.64 500 14.20 - - 5506 6.79 2161 8.42 779 18.87
47 2023-11-25 9427 7.62 620 11.94 - - 5716 5.86 2186 7.55 883 15.63
48 2023-12-02 10068 6.79 676 9.76 - - 5970 5.19 2427 6.47 959 15.43
49 2023-12-09 9980 6.00 668 6.74 - - 6046 4.50 2516 6.20 695 17.70
50 2023-12-16 11005 5.90 730 7.81 - - 6708 4.62 2437 4.97 1059 14.45
51 2023-12-23 10800 5.56 768 6.51 - - 6434 3.73 2380 5.88 1154 14.47
52 2023-12-30 10881 4.71 709 5.50 - - 6808 3.30 2155 4.83 1145 12.31
1 2024-01-06 11366 4.80 812 4.43 - - 7012 3.76 2268 5.51 1197 9.69
2 2024-01-13 11322 4.43 924 4.22 - - 7146 3.20 2090 5.07 1089 11.48
3 2024-01-20 9564 4.59 704 4.26 - - 6103 3.16 1751 6.40 968 10.02
4 2024-01-27 9212 4.37 834 4.68 - - 5678 3.12 1695 6.02 961 8.43
5 2024-02-03 9317 5.02 794 5.54 - - 5534 3.27 1918 7.66 1035 9.08
6 2024-02-10 8831 6.26 782 8.82 - - 5191 4.26 1909 7.54 918 12.42
7 2024-02-17 8854 6.18 619 6.30 - - 5376 4.35 1882 8.29 941 12.01
8 2024-02-24 8644 6.21 632 5.85 - - 5113 4.99 1896 7.23 945 10.69
9 2024-03-02 8601 6.48 587 6.30 - - 5157 4.65 1773 7.61 1041 13.74
10 2024-03-09 8230 6.52 483 9.11 - - 4991 4.81 1734 7.55 956 12.45
11 2024-03-16 8300 6.67 626 6.55 - - 5084 5.39 1593 7.34 964 12.03
12 2024-03-23 8413 6.63 592 7.26 - - 5085 5.45 1795 7.30 900 11.56
13 2024-03-30 7847 7.37 581 8.61 - - 4589 5.14 1745 9.91 909 12.87
14 2024-04-06 7608 7.39 598 10.54 - - 4634 6.15 1579 8.36 762 10.10

Positive human coronavirus (HCoV) tests

Figure 10: Positive human coronavirus (HCoV) tests (%) in Canada by region by surveillance week
Figure 10
Figure 10: Positive human coronavirus (HCoV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HCoV% Atl Tests HCoV% QC Tests HCoV% ON Tests HCoV% Pr Tests HCoV% BC Tests HCoV%
35 2023-09-02 5054 0.28 362 0.00 847 0.47 2230 0.13 1007 0.60 608 0.16
36 2023-09-09 5195 0.42 355 0.56 868 0.81 2285 0.09 1171 0.77 516 0.39
37 2023-09-16 6174 0.23 401 0.50 1053 0.47 2636 0.23 1362 0.00 722 0.14
38 2023-09-23 6796 0.46 429 0.00 1122 0.80 2995 0.40 1503 0.40 747 0.54
39 2023-09-30 7026 0.28 401 0.00 1117 0.45 3325 0.21 1468 0.48 715 0.14
40 2023-10-07 7305 0.26 467 0.21 1178 0.08 3390 0.18 1587 0.25 683 1.02
41 2023-10-14 7435 0.32 491 0.20 1094 0.73 3461 0.12 1672 0.60 717 0.14
42 2023-10-21 7697 0.17 498 0.20 1050 0.48 3707 0.05 1747 0.23 695 0.14
43 2023-10-28 7576 0.38 473 0.42 1065 0.38 3707 0.30 1694 0.53 637 0.47
44 2023-11-04 7754 0.37 476 0.21 1067 0.28 3508 0.43 1967 0.20 736 0.82
45 2023-11-11 8119 0.42 467 0.86 1187 0.51 3607 0.28 2115 0.38 743 0.81
46 2023-11-18 8674 0.65 500 0.20 1324 0.98 3838 0.42 2233 0.99 779 0.51
47 2023-11-25 9069 0.65 620 0.65 1357 0.96 3977 0.55 2232 0.54 883 0.91
48 2023-12-02 9880 0.76 676 0.74 1518 1.05 4241 0.42 2486 0.72 959 1.88
49 2023-12-09 9440 1.12 668 1.20 1523 1.64 4007 0.57 2547 1.33 695 2.30
50 2023-12-16 10458 1.47 730 0.41 1583 1.58 4616 1.47 2470 1.58 1059 1.79
51 2023-12-23 10483 1.77 768 1.30 1765 2.10 4389 1.66 2407 1.58 1154 2.43
52 2023-12-30 10328 2.48 709 1.55 1885 2.97 4422 2.49 2167 2.08 1145 2.97
1 2024-01-06 10903 3.06 812 2.96 1861 2.10 4722 3.37 2311 2.81 1197 3.93
2 2024-01-13 10891 3.19 924 3.03 1719 2.50 5030 3.14 2129 3.85 1089 3.31
3 2024-01-20 9527 3.89 704 5.11 1698 4.18 4360 3.78 1797 3.78 968 3.20
4 2024-01-27 9111 5.19 834 5.28 1640 5.49 3941 5.76 1735 4.27 961 3.95
5 2024-02-03 9137 5.10 794 4.79 1647 5.10 3717 6.27 1944 3.34 1035 4.44
6 2024-02-10 8766 6.80 782 5.37 1653 9.50 3456 7.00 1957 5.01 918 6.21
7 2024-02-17 8846 7.73 619 6.30 1700 8.12 3661 8.96 1925 6.39 941 5.95
8 2024-02-24 8546 8.28 632 7.28 1644 10.28 3416 8.17 1909 7.02 945 8.47
9 2024-03-02 8590 7.09 587 6.47 1643 7.49 3511 8.32 1808 5.53 1041 5.38
10 2024-03-09 8072 6.84 483 4.97 1522 6.96 3342 8.02 1769 5.48 956 5.96
11 2024-03-16 8007 7.18 626 4.95 1287 7.30 3476 8.20 1654 6.83 964 5.39
12 2024-03-23 8202 6.79 592 6.08 1455 6.19 3452 7.42 1803 6.60 900 6.22
13 2024-03-30 7793 6.01 581 6.54 1418 5.85 3111 6.49 1774 5.02 909 6.16
14 2024-04-06 7508 6.71 598 7.19 1483 6.14 3069 6.81 1596 7.02 762 6.43

Page details

Date modified: